In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics (ASX:LDX) has signed an exclusive six-year distribution agreement with PHASE Scientific, valued at up to US$317 million (A$487 million), for the supply of its flagship test, FebriDx®. Targeting a High-Growth Market The deal places Lumos’ FebriDx® at the forefront of
Read More
The race to enable faster, smarter, and lower-power edge AI systems is intensifying – and dorsaVi (ASX:DVL) is stepping up with validation data that positions its next-gen RRAM (Resistive Random-Access Memory) technology as a serious contender in the embedded systems space. With the global surge in demand for AI-capable wearable devices, robotics, and autonomous edge
Read More
Semiconductor Market Opens Door to Global Expansion Australian tech innovator Nanoveu (ASX:NVU) has locked in a strategic $2 million placement to accelerate the commercial rollout of its ECS-DoT chip and EMASS modular AIoT platform – two technologies that sit at the heart of next-gen edge computing and smart device development. The funding comes at a
Read More
ASX-listed semiconductor company Archer Materials (ASX:AXE) has hit a key technical milestone, demonstrating that its tunnel magnetoresistance (TMR) sensor technology can function in extreme cryogenic conditions. The result opens the door to potential application across multiple quantum computing platforms and sets the foundation for broader commercial opportunities in advanced sensing markets. TMR Sensors Show Promise
Read More
PFAS Regulation Drives Urgent Market Need As global pressure mounts to tackle man-made chemicals, The Environmental Group Limited (ASX:EGL) has secured a new $1.9 million contract for the design and construction of a PFAS (per- and polyfluoroalkyl substances) treatment plant – its first commercial deployment of proprietary PFAS separation technology. PFAS are synthetic compounds used
Read More
In a move that underlines the growing role of automation in the resources sector, RocketDNA Ltd (ASX:RKT) has inked a new 18-month contract with Vault Minerals (ASX:VAU) for advanced aerial data services at the King of the Hills (KOTH) gold operation in Western Australia. The agreement, worth an estimated $705,000, significantly expands on RocketDNA’s previous
Read More
Australia’s broadcast technology sector is experiencing rapid global expansion, driven by demand for IP video production tools and live streaming capabilities across enterprise, education, and media. Within this niche, BirdDog Technology (ASX:BDT) has made a name for itself with high-performance, Network Device Interface (NDI)-enabled video solutions. Now, the company is preparing for a major structural
Read More
Advanced Manufacturing Hits U.S. Soil AML3D Limited (ASX:AL3), a leader in Wire-arc Additive Manufacturing (WAM®), has officially opened its new Technology Facility in Stow, Ohio, a major milestone in expanding America’s advanced manufacturing capabilities and deepening the AUKUS defence collaboration. The plant also creates new jobs in the Ohio economy. Supporting Submarines and Security The
Read More
Vection Technologies (ASX:VR1) has announced a $520,000 partnership with Rider Srl, part of the Italian Procmatech Group, to co-develop a modular robotics platform aimed at revolutionising open-field agriculture. The agreement marks Vection’s entry into the fast-expanding agricultural robotics sector – projected to grow to US$48 billion by 2030 – and reflects increasing demand for AI-driven
Read More
Digital human and conversation design solutions company Unith Limited (ASX:UNT) has announced strong year-on-year growth in its platform usage metrics and Strategic Partner collaborations, highlighting significant traction for its proprietary technology platform and product offerings. The uplift has been achieved without heavy marketing expenditure, indicating that the company’s solutions are organically resonating with target markets
Read More
Robotic technology company FBR Limited (ASX: FBR, OTCQB: FBRKF) has officially entered into an Engineering Service Agreement with Samsung Heavy Industries (SHI), marking the commencement of the first phase of a shipbuilding automation project aimed at revolutionising the global ship construction process. This agreement represents a significant milestone in FBR’s expansion into new applications for
Read More
Industry Growth Opens Doors for Pharma Innovators With the global psychedelic drugs market projected to reach A$14 billion by 2032, and the medical cannabis sector already generating more than A$3 billion annually across Australia, Germany, the UK and the EU, Bioxyne Limited (ASX:BXN) is growing revenues as it meets increased demand. The company announced an
Read More
In a move that impacts the future of wearable sensing and edge computing, Australian motion-analysis company dorsaVi (ASX:DVL) has secured exclusive worldwide rights to a transformative memory technology developed by Singapore’s Nanyang Technological University (NTU). The deal grants dorsaVi access to nine families of resistive random-access memory (RRAM) patents designed to power the next generation
Read More
A Transformative $14 Billion Merger In a bold move that will reshape Australia’s industrial and investment sectors, Washington H. Soul Pattinson (ASX:SOL) and Brickworks (ASX:BKW) have agreed to a transformative merger that will create a new $14 billion ASX-listed entity. The deal will dismantle their long-standing cross-shareholding and replace it with a unified, more investable
Read More
TruScreen Group Limited (NZX/ASX:TRU), a medical device company focused on real-time cervical cancer screening, has raised NZ$2.35 million from a share placement that drew strong interest from investors across Asia, including some new investors from Singapore and Hong Kong. These additional funds will be used to advance the company’s AI-powered cervical cancer detection technology amid
Read More
Expanding Western Australia’s Gold Processing Capacity The Australian resources sector has gained fresh momentum as Saunders International Limited (ASX:SND) announced a significant contract win. The $27 million agreement, awarded by Primero, marks Saunders’ continued involvement in enhancing operations at Kalgoorlie Consolidated Gold Mines (KCGM), one of Western Australia’s iconic mining sites. This contract will see
Read More
A growing U.S. demand for faster, AI-powered tools in cardiopulmonary care is opening up substantial commercial opportunities for Australian medtech company 4DMedical (ASX:4DX). The Melbourne-based imaging innovator has secured a significant contract with Intermountain Health—one of the United States’ largest and most respected health systems—for the rollout of its newly FDA-cleared Pulmonary Hypertension Analysis (PHA™)
Read More
Race Oncology (ASX:RAC) has taken a step towards the development of a new cancer-fighting drug therapy, dosing the first patient in its Phase 1 trial of RC220, a reformulated version of bisantrene, aimed at treating advanced solid tumours. The early-stage trial marks a key milestone for Australia’s biotech sector and positions Race Oncology at the forefront
Read More
The March 2025 quarter CPI data released today were a touch above market expectations. The headline CPI rose by 0.9% over the quarter, well up on the slight 0.2% increase reported in the prior quarter. This delivered an annual CPI increase in the March 2025 quarter of 2.4%, which matched that reported in the prior
Read More
Australian biotech PYC Therapeutics (ASX:PYC) has taken a major step forward with its lead program, presenting clinical data that signals a significant opportunity in the treatment of genetic eye diseases — a space where no treatments currently exist. The company announced that interim results from its Phase 1/2 trials for VP-001 — a drug candidate
Read More
Australia’s Push To Lead In High Purity Alumina (HPA) Impact Minerals (ASX:IPT) has secured a 50% stake in Alluminous Pty Ltd, which recently acquired the high-potential HiPurA® HPA processing technology. The move is a step in Impact’s strategy to become a vertically integrated HPA producer and could shave years off its path to commercialisation. “This
Read More
Equity Story Group Taps Booming Advisory Sector Equity Story Group Ltd (ASX:EQS) has taken a major step into full-service wealth management, signing a binding agreement to acquire long-standing financial advisory firm Baker Young Limited. The strategic acquisition aims to expand Equity Story’s footprint into retail stockbroking and corporate advisory—two segments showing significant growth amid increasing
Read More
Independent Resource Estimate Highlights Massive Oil Exploration Upside A new independent assessment has confirmed a best estimate of 3 billion barrels of oil across five high-impact exploration prospects offshore northern Peru — putting Condor Energy (ASX:CND) firmly on the radar of investors seeking exposure to large-scale frontier oil opportunities. “The independent resource estimate … validates
Read More
Federal Funding Unlocks New Health Access Opportunity Atomo Diagnostics (ASX:AT1) has received a $230,000 order from Thorne Harbour Health (THH) to support the national rollout of its HIV self-test kits through public-funded vending machines. The initiative is part of the Federal Government’s CONNECT Programme, announced in the May 2024 Budget, and signals a shift toward
Read More
Funding Injection Strengthens Spenda’s Push Towards Operational Break-Even Spenda Limited (ASX:SPX) has executed a $3 million term loan facility with Capricorn Society Limited. The facility bolsters Spenda’s financial position and signals confidence in its strategic direction, The facility’s flexible funding arrangement is designed to support the company’s capital expenditure and working capital requirements as it
Read More
Cannabinoid Therapy Gains Foothold in Germany’s Epilepsy Market Argent BioPharma (ASX:RGT) has secured approval for its flagship cannabinoid-based epilepsy treatment, CannEpil™, to be prescribed in Germany. This milestone marks a major step in the company’s European expansion and strengthens its presence in one of the region’s key pharmaceutical markets. Germany has approximately 816,000 epilepsy patients,
Read More
Enmore Gold Project Shows Exploration Potential Koonenberry Gold (ASX:KNB) has returned high-grade gold intercepts from its first diamond drillhole at the Enmore Gold Project in northeast New South Wales. The results validate historical drill data and highlight the potential for a significant mineralised system. Managing Director Dan Power described the outcome as “a truly exciting
Read More
Property Market Shift Opens Opportunities Australia’s property sector continues to attract strong investor interest, with major players eyeing strategic acquisitions. AVJennings Limited (ASX:AVJ) has now entered into a Scheme Implementation Deed (SID) with AVID Property Group, in partnership with Proprium Capital Partners, in a deal valued at $0.655 per share. This agreement provides a significant
Read More
Funding Agreement with Deutsche Balaton AG Altech Batteries (ASX:ATC) has entered into a bearer bond agreement with major shareholder Deutsche Balaton AG, allowing the company to access up to €2.5 million in funding. The agreement, which requires shareholder approval, will provide cash in increments of €500,000. The interest payable on the bearer bonds will be
Read More
Fertility Tech Market Expands, With Memphasys Ready to Capitalise The global assisted reproductive technology (ART) sector continues to grow rapidly, with IVF cycles projected to exceed 4 million annually by 2030. The demand for technologies that improve embryo success rates is stronger than ever — and Memphasys (ASX:MEM) with its Felix™ System appears poised to
Read More
The opportunity for next-generation energy storage continues to grow, and GreenHy2 Limited (ASX:H2G) has taken a step forward by signing a contract with European supplier H2Core. The agreement provides GreenHy2 with access to leading-edge supercapacitor battery and hydrogen storage technologies, offering significant advantages in cost, safety, and operational efficiency over traditional solutions. Supercapacitor Batteries Promise
Read More
Baghdad Safe City Project Drives Major Milestone for Australian AI Company The Middle East continues to show strong demand for advanced security technology, and Australian AI video analytics firm icetana Limited (ASX:ICE) has seized the moment. The company has secured its largest contract to date — an A$1.7 million purchase order for its AI-powered video
Read More
A major opportunity is emerging for early stroke and brain injury diagnosis in remote and aeromedical settings, as EMVision’s (ASX:EMV) First Responder device passes its first critical air-based test. Stroke and traumatic brain injury (TBI) are two of the most time-sensitive medical emergencies. In regional Australia, patients face long delays to diagnosis and specialist care
Read More
Voicemail Market Evolves with AI Opportunity The growing demand for modern, AI-driven telecommunications services has opened up a new industry opportunity—and Norwood Systems (ASX:NOR) is positioning itself to capitalise. Norwood develops advanced voice communication platforms leveraging conversational and generative AI technologies. The company has signed a five-year supply contract with Optus to replace its existing
Read More
Industry Headwinds Open the Door for Shareholder Certainty The Asian gaming and entertainment sector faces increasing complexity as regulatory shifts and border operational risks continue to challenge smaller operators. Against this backdrop, Donaco International Limited (ASX:DNA) has announced a proposed acquisition by On Nut Road Limited (ONR), an Argyle Street Management (ASM)-backed investment vehicle. A
Read More
Helium Market Gains a New Supplier Renergen (ASX:RLT) has taken a significant step forward in the global helium market, announcing its first successful commercial fill of liquid helium. The milestone marks the company’s transition from development to sales, a crucial moment for investors tracking the Virginia Gas Project’s progress. The global helium market has faced
Read More
Ethics Approval Clears Path for RC220 Clinical Trial Race Oncology (ASX:RAC) has received a major regulatory green light, with the Bellberry Human Research Ethics Committee (HREC) granting approval for its Phase 1 clinical trial of RC220 in combination with doxorubicin for solid tumour patients. This milestone enables the lead site, Southside Cancer Care Centre in
Read More
Predictive Test Aims to Revolutionise Kidney Disease Management Australia’s healthcare system is facing a growing challenge: diabetes-related kidney disease. With over 1.3 million Australians living with diabetes, more than half are at risk of developing chronic kidney disease (DKD), a leading cause of dialysis and kidney failure. In a significant step forward, Proteomics International Laboratories
Read More
Addressing Critical Gaps in Autism Diagnosis Autism spectrum disorder (ASD) affects millions of children worldwide, yet early diagnosis remains a major challenge. Despite recommendations from the American Academy of Paediatrics (AAP) for autism screening at 18 and 24 months, many children experience delays in diagnosis, missing the crucial window for early intervention. BlinkLab Limited (ASX:BB1)
Read More
Lupin Protein Gains Global Momentum Wide Open Agriculture (ASX:WOA) is making significant strides in the global plant-based protein market, securing initial commercial sales and purchase orders across five continents. This latest development highlights the growing demand for WOA’s lupin protein isolates, and positions the company as a key player in the alternative protein sector. “These
Read More
Kanmantoo’s Output Surges as Operations Strengthen Hillgrove Resources (ASX:HGO) has delivered a record-breaking month at its Kanmantoo Copper Mine, producing 1,105 tonnes of copper in February 2025. This marks the highest monthly production since the site began processing underground material in February 2024, reinforcing the mine’s steady operational improvement. CEO Highlights Operational Gains Hillgrove CEO
Read More
Renewable Gas Gains Momentum with Delorean’s SA1 Project The push for renewable energy in Australia has received a major boost, with Delorean Corporation Ltd (ASX:DEL) securing a $6.08 million grant from the Australian Renewable Energy Agency (ARENA). The funding will accelerate the development of the company’s SA1 bioenergy facility in Edinburgh Parks, South Australia. Delorean
Read More
AI Innovation Opens New Doors in Health Monitoring Spacetalk Ltd (ASX:SPA) has taken a significant step in its transformation journey by securing an exclusive, worldwide licence for Watch Walk AI, an AI-powered gait biomarker algorithm. Developed by a team of researchers from Neuroscience Research Australia (NeuRA) and the University of New South Wales (UNSW), this
Read More
Crypto Payments Opportunity Grows as InFocus Wins Multi-Phase Deal The global demand for seamless, cross-border payment solutions continues to rise, with stablecoin technology emerging as a key player in the financial landscape. Australian-listed data analytics and software solutions company InFocus Group Holdings Limited (ASX:IFG) has secured a US$1.5 million service agreement with GBO Assets Ltd,
Read More
Strong Start to calendar 2025 with Robust Sales Growth Reported Forbidden Foods Ltd (ASX:FFF) has kicked off the 2025 calendar year with a strong sales performance, reporting a 147% increase in year-to-date sales compared to the previous corresponding period. For the first two months of the year, the company recorded net sales of $577,857, reflecting
Read More
Vinyl Group Seizes Growth Opportunity in Digital Media Vinyl Group (ASX:VNL), Australia’s only ASX-listed music company, has completed its acquisition of digital city guide Concrete Playground for $5.56 million. This strategic move strengthens Vinyl Group’s media and advertising division, positioning the company for accelerated growth and a faster path to positive cash flow. CEO Josh
Read More
Tool Market Opportunity Expands with Major Brand Agreements The Australian and New Zealand power and hand tool market is set for a shake-up as Stealth Group Holdings Ltd (ASX:SGI) secures exclusive distribution rights for CAT® Power Tools, Wesco Power Tools, and Harden Hand Tools. This move significantly strengthens Stealth’s exclusive brand strategy, positioning it as
Read More
BlueBet Targets Growth with PointsBet Takeover Australia’s online wagering sector is set for a shake-up as BlueBet Holdings Limited (ASX:BBT) has made an offer to acquire PointsBet Holdings Limited in a deal valued between $340 million and $360 million. If successful, the acquisition is expected to generate at least $40 million in annual synergies, positioning
Read More
Despite a challenging macroeconomic environment, Nickel Industries Limited has achieved remarkable milestones in its 12 months ended 31 December 2024 financial year, setting new production records and securing strategic acquisitions that strengthen its position as a leading global nickel producer. The company produced an impressive 135,602 tonnes of finished nickel metal across Nickel Pig Iron
Read More
Expanding Digital Maternity Care with Wearable Technology HeraMED (ASX:HMD), a leader in digital maternity care, has secured a strategic collaboration with global smartwatch giant Garmin (NYSE:GRMN). The agreement enables seamless integration of Garmin’s smartwatch data into HeraMED’s remote pregnancy monitoring platform, HeraCARE—offering expectant mothers and healthcare providers a more comprehensive view of maternal health. HeraMED
Read More
Cosette’s Offer Price Well In Excess of Mayne’s Last Close Mayne Pharma (ASX:MYX) has received a takeover offer from U.S.-based Cosette Pharmaceuticals, Inc., marking a major milestone in the Australian pharmaceutical sector. The agreement, structured as a Scheme of Arrangement, will see Cosette acquire 100% of Mayne Pharma’s shares for $7.40 per share, valuing the
Read More
Industry Sees Growth in Digital Health and Medicinal Cannabis The digital health and medicinal cannabis sectors are rapidly evolving, with demand for telehealth services and alternative treatments on the rise. Vitura Health Limited (ASX:VIT) is capitalising on this opportunity, having officially completed its acquisition of Candor Medical, a provider of innovative prescription treatments via telehealth.
Read More
Aquaculture Sector Sees Major Opportunity The Australian aquaculture industry is on the brink of a significant shake-up as Clean Seas Seafood Limited (ASX:CSS) considers a merger proposal from Yumbah Aquaculture Ltd. If successful, the deal would combine two leading Australian seafood producers, bringing together Clean Seas’ premium Yellowtail Kingfish operations with Yumbah’s extensive shellfish portfolio.
Read More
Wind Energy Opportunity Expands in New Zealand The renewable energy sector in New Zealand is poised for significant growth, with Meridian Energy Limited (ASX/NZX:MEL) announcing its intention to acquire full ownership of NZ Windfarms Limited (NZX:NZWF). The acquisition will provide Meridian with complete control over NZ Windfarms’ assets, including the pivotal Te Rere Hau Wind
Read More
In a move that has brought a smile to the faces of personal and business borrower alike (and a few under-the-pump politicians!), the Reserve Bank of Australia (RBA) reduced its benchmark interest rate by 25 basis points to 4.10% at its 17-18 February 2025 Board meeting. The last time this benchmark rate was reduced was
Read More
USD 26 Billion Market Opportunity The global market for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) is expected to grow from USD 7.3 billion in 2018 to USD 26 billion by 2032, highlighting an urgent need for effective new treatments. With the rise of antimicrobial resistance (AMR), demand for novel broad-spectrum antibiotics is at
Read More
A Strategic Move into AI-Driven Automotive Solutions The automotive industry is at a turning point, driven by the rise of connected cars, changing customer expectations, and a need for efficiency. As businesses scramble for smarter solutions, Infomedia Ltd (ASX:IFM) has made a bold move—securing a 50% stake in European AI startup Intellegam GmbH for €6.1
Read More
Industry Opportunity: Addressing a Critical Unmet Need The fight against blood cancer is evolving, and Imugene Limited (ASX:IMU) is at the forefront of this battle. With a new wave of promising results from its Phase 1b trial, Imugene’s allogeneic off-the-shelf CD19 CAR-T therapy, azer-cel, is demonstrating significant potential for patients with relapsed/refractory diffuse large B-cell
Read More
A Game-Changer for Critical Metals Supply The global semiconductor and defence industries are facing a critical supply chain challenge, with key materials like gallium (Ga) and germanium (Ge) largely controlled by Chinese exports. MTM Critical Metals (ASX:MTM) has taken a major step towards addressing this issue, achieving high recovery rates of these metals from semiconductor
Read More
Vinyl Group seizes cultural opportunity with premium publishing expansion Vinyl Group (ASX:VNL) is making bold moves in the Australian media landscape, unveiling a major rebrand and restructure of its media division as Vinyl Media. The company, Australia’s only ASX-listed music entity, is positioning itself as a powerhouse for cultural storytelling, blending premium publishing with audience
Read More
Advanced Sperm Selection Technology Moves Closer to Market Memphasys Limited (ASX:MEM) has hit a critical milestone in its pivotal clinical trial for the Felix™ System, an innovative sperm selection technology designed for Assisted Reproductive Technology (ART) procedures. With the Last Patient Last Visit (LPLV) now completed, the company is entering the final phase before results
Read More
New Imaging Breakthrough Targets Growing Brain Metastases Challenge Brain metastases are becoming increasingly prevalent due to improved cancer treatments extending patient survival. However, accurate detection remains a major clinical challenge. A new study highlights promising results for Radiopharm Theranostics’ (ASX:RAD, NASDAQ: RADX) novel imaging agent, RAD 101 (18F-Pivalate), in detecting brain metastases with high precision.
Read More
Seizing an Opportunity in Affordable Rentals With home ownership in Australia becoming increasingly out of reach and rental demand surging, the all-age rental sector presents a significant growth opportunity. According to the most recent National Census, nearly 30% of Australians rent their homes, and 85% of these renters are under the age of 55. Eureka
Read More
Indonesia’s gaming industry is on a rapid growth trajectory, driven by a tech-savvy, youthful population and increasing government support for esports. With over 8.3 million dedicated PC gamers, the market presents a significant opportunity for digital entertainment providers. SportsHero Limited (ASX: SHO) has now secured a key position in this expanding sector through a two-year
Read More
Altair Minerals Limited (ASX: ALR) has announced the proposed acquisition of the Venatica Copper Project in Peru, If completed, this transaction would position the company within one of the world’s most prolific copper-producing regions. Located just 60km from Monger Gold’s (ASX:MMG) Las Bambas Mine, which is responsible for 2% of the world’s copper supply. Venatica
Read More
The fight against pancreatic cancer has taken a step forward in Germany, with 120 hospitals now legally entitled to negotiate funding for OncoSil Medical’s (ASX:OSL) innovative treatment device. This marks a 43% increase from the previous year and highlights growing recognition of the OncoSil™ device within the German healthcare system. German Hospitals Embrace OncoSil’s Innovation
Read More
Tackling a Major Health Challenge Gastrointestinal (GI) diseases, including colorectal cancer, are a significant global health issue. In 2020 alone, there were an estimated 1.9 million new cases of colorectal cancer and more than 930,000 related deaths worldwide. Early detection and precise intervention are crucial, but traditional diagnostic methods often lack the real-time precision required
Read More
Slightly below expectations December 2024 quarter CPI data released today were warmly received by stock market investors. The stats, which have ramifications for Australia’s monetary policy settings, bolstered hopes that the Reserve Bank of Australia (RBA) will reduce its benchmark interest rate ahead of the next Federal election, which must be held by May 2025.
Read More
In a strategic move to bolster its governance and corporate strategy, OncoSil Medical Limited (ASX:OSL), a leader in pancreatic cancer treatment innovation, has today appointed Ms. Lel Smits as a Non-Executive Director. The addition of Ms. Smits, a renowned figure in corporate governance and investor relations, signals OncoSil’s commitment to enhancing its market position and
Read More
RYONCIL® (remestemcel-L) becomes the first mesenchymal stromal cell (MSC) product approved by the US Food and Drug Administration (FDA) for any indication. RYONCIL® is also the first FDA-approved therapy for children aged 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), a life-threatening condition with high mortality rates.
Read More
Calls from some quarters for the RBA to slip an interest rate cut into borrowers’ Christmas stockings have gone unheeded, with the Bank’s benchmark interest rate remaining at 4.35% following its December 2024 Board meeting. This closely-watched rate has now been set at 4.35% since December last year. What kept the RBA from changing the
Read More
“This ARCEMY® X order from the TVA is very much aligned with the US Scale Up growth strategy we have in place,” said AML3D CEO Sean Ebert, as the company announced a landmark A$2.27 million contract to supply the Tennessee Valley Authority (TVA) with its large-scale ARCEMY® X system. The deal marks AML3D’s strategic expansion beyond
Read More
Australia’s economic growth, as measured by the ABS-compiled chain volume GDP statistics that adjust for price increases, rose by a paltry 0.3% in the September 2024 quarter, to be just 0.8% higher on an annual (through the year) basis. The markets were expected Australia’s quarterly economic growth increase to be around 0.5% in the latest
Read More
Invion (ASX:IVX) surged higher after announcing that it had completed the dosing of the first patient in its Phase I/II non-melanoma skin cancer (NMSC) trial conducted at Veracity Clinical Research (Veracity) in Brisbane. The trial marks a significant milestone for Invion and is designed to evaluate the safety and efficacy of its lead drug candidate
Read More
Mineral exploration business Wildcat Resources (ASX: WC8) has unveiled a significant resource estimate for its Tabba Tabba project in the Pilbara region of Western Australia, consisting of 74.1 million tonnes at a grade of 1.0 per cent lithium. According to the company, the project now holds Australia’s largest undeveloped publicly reported hard-rock lithium deposit. The
Read More
AML3D (ASX:AL3) announced the successful completion of a two-tranche institutional placement (“Placement”) to sophisticated investors, raising approximately $30 million. The Placement will see around 157.9 million new fully paid ordinary shares in AML3D issued at a price of $0.19 per share. The Placement was strongly supported by both existing AML3D shareholders and new institutional investors
Read More
Encounter Resources (ASX:ENR) rose after announcing that the first reverse circulation (RC) drilling results from its Green prospect at the Aileron project in the West Arunta region of WA hosts extensive, enriched, high-grade niobium mineralisation in the upper portion of the system. Of the four initial RC holes completed in Green’s western area, three returned
Read More
Medical technology company Singular Health Group rose after it announced the signing of a Memorandum of Understanding (MOU) with Provider Network Solutions (PNS) to collaborate on a technical proof-of-concept and commercial pilot within the PNS Network. Singular Health also announced the completion of a successful equity placement of AUD3.7M at $0.09 per share, including an
Read More
The share price of healthcare technology and services business Resonance Health (ASX: RHT) surged by more than 50 per cent on Tuesday after the company nailed down a two-year clinical trial agreement with Indian multinational pharmaceutical titan, Sun Pharmaceuticals. The $13.775 million deal will see Resonance act as the local Australian sponsor and provide clinical
Read More
Petratherm (ASX:PTR) rallied strongly after announcing results from an initial trial heavy mineral sand (HMS) separation test using samples collected from historic drill holes stored at the South Australian Core Library (CAR series drill holes). The composite samples were collected from widely spaced contiguous drill holes along a 2.5-kilometre-long traverse on the eastern side of
Read More
Spectur (ASX: SP3), a specialist in smart security systems powered by solar technology, has locked in a three-year agreement valued at close to $800,000 for the provision of its cameras and analytic services to government agency Transport for New South Wales. The contract also allows for a potential site expansion which could help boost the
Read More
The Australian mining industry flocked to tropical Queensland this week for one of the most distinguished events on the calendar for ASX-listed producers, explorers, and resource developers: the Noosa Mining Investor Conference hosted by Brisbane-based outfit, Equity Events. Held twice a year at the Peppers Noosa Resort on the top end of Queensland’s pristine Sunshine
Read More
Biome Australia (ASX: BIO), a healthcare business specialising in developing, marketing, and distributing probiotic and complementary health products, has spread its wings into the Canadian market after generating positive feedback and encouraging early sales during a two-month testing period. Management believes the Canadian market is now adequately derisked for the company to march forward with
Read More
Medical device company EMVision (ASX: EMV) has reported “excellent” results from a study gauging the effectiveness of its cutting-edge neurodiagnostic technology for the identification of stroke and stroke types. The multi-site study – known as EMView – involved the testing of diagnostic algorithms on unseen data from 307 participants across the Liverpool, Royal Melbourne, and
Read More
Battery technology business Novonix (ASX: NVX) has entered a binding offtake agreement to supply its high-performance synthetic graphite material to the battery cell manufacturing partners of multinational automotive titan, Stellantis. Commencing in 2026, the six-year deal will see Novonix deliver a minimum of 86,250 tonnes of graphite and up to 115,000 tonnes of the material
Read More
Equinox Resources (ASX: EQN) rallied after announcing that reconnaissance assay results from the maiden exploration program at its Alturas antimony project in British Columbia, Canada had returned ultra-high grade naturally occurring antimony, with assays up to 69.98% antimony. Equinox Resources also announced an expansion of its Alturas project, with the Company pegging two additional claims
Read More
Quickstep Holdings (ASX:QHL) has had a busy day, announcing (1) the successful finalisation of key negotiations with its Tier 1 defence customers, incorporating terms that reflect mutually acceptable volumes and pricing adjustments and (2) a takeover offer from ASDAM Operations Pty Limited. Contracts update C-130 Program with Lockheed Martin: Quickstep Holdings secures volume and increased
Read More
Second Benchmark testing for the ECS-DOT chipset by Embedded A.I Systems Pte. Ltd (EMASS) is scheduled to commence on 7 November, 2024, with results expected within a week The tests will focus on two critical applications, Anomaly Detection and Keyword Spotting, using standardised workloads from the MLPerf Tiny AI suite The EMASS ECS-DOT’s chipset performance
Read More
Those calling for the RBA to cut its benchmark interest rate on Melbourne Cup have backed the wrong horse – all they got was a hoarse voice! The RBA statement accompanying the Bank’s 5 November 2024 rates decision clearly stated the obstacles to any near term rate cut – and reiterated its ‘highest priority’, which
Read More
Clinical stage immuno-oncology company Imugene Limited (ASX:IMU) provided a clinical trial update of its Phase 1 MAST (Metastatic Advanced Solid Tumours) trial evaluating the safety and efficacy of novel cancer-killing virus CF33-hNIS (VAXINIA). Patient hits major milestone in CF33 MAST VAXINIA study, with ‘complete response’ for over two years The Cohort review committee has cleared
Read More
Ordell Minerals (ASX:ORD) has reported ‘significant drill results’ from its recent shallow, wide-spaced Reverse Circulation (RC) drilling program at the Company’s Barimaia Gold Project, located near Mount Magnet in the WA-based Murchison region. These RC drilling activities, completed in September and October 2024, represented the second phase of Ordell Minerals’ larger, ongoing program to systematically
Read More
Diversified mining business Mineral Resources (ASX:MIN) has struck a deal with Gina Rinehart’s Hancock Prospecting for the sale of two of its oil and gas exploration permits in the Perth Basin of Western Australia. In addition, the duo has entered joint venture (JV) agreements over Mineral Resources’ remaining exploration ground in the Perth Basin and
Read More
Shares in mineral exploration business OD6 Metals (ASX: OD6) rocketed by 75 per cent on Wednesday after the group reported its proposed acquisition of one of Australia’s highest grade historical copper mines, known as the Gulf Creek project. Located near the town of Burra in New South Wales, Gulf Creek is a volcanogenic massive sulphide
Read More
Digital financial services business Zip Co (ASX: ZIP) saw its share price jump by 12 per cent on Tuesday after delivering a strong set of numbers for the first quarter of FY25. Notably, group cash operating earnings (EBITDA) of $31.7 million soared by 234 per cent from the same time last year as the company
Read More
Commercial-stage biopharmaceutical business Telix Pharmaceuticals (ASX: TLX) has moved a step closer to bringing to market its brain tumour imaging product known as Pixclara, after receiving ‘New Drug Application’ (NDA) status from the US Food and Drug Administration (FDA). The company’s formal application has now been granted priority review by the FDA, with a commercial
Read More
Technology services and solutions business Adisyn (ASX: AI1) appears set to broaden its exposure to the burgeoning semiconductor sector through a proposed acquisition of innovative high-tech company, 2D Generation. The deal could see Adisyn boost its penetration into target markets such as data centres, cybersecurity, and the defense industry. The tabled acquisition builds on
Read More
Mineral exploration business Yandall Resources (ASX: YRL) saw its share price double on Monday after the group delivered an “exceptional” gold hit from drilling at its New England Granite prospect, located within the company’s broader tenure at its flagship Well-Barwidgee gold project in Western Australia. The wide 78 metre intercept grading 1.2 grams per tonne
Read More
Shares in biotechnology business Nyrada (ASX: NYR) lifted by nearly 40 per cent on Wednesday following the successful completion of safety studies on its lead drug candidate for the treatment of traumatic brain injury and strokes, NYR-BI03. The favourable results have now opened the door for a first clinical trial of the drug on humans
Read More
Clean energy and high-tech materials company AnteoTech (ASX: ADO) has received a first commercial order for its proprietary Ultranode battery anode technology which contains 70 per cent silicon. The initial $40,000 purchase will see an unnamed “major” European electric vehicle (EV) manufacturer – known as EV1 – test and evaluate the technology over the coming
Read More
Shares in mineral exploration business African Gold (ASX: A1G) more than doubled on Tuesday after the company delivered “spectacular” gold intercepts from drilling at its Didievi project in the West African nation of Côte d’Ivoire. The new results from one diamond drill hole at the Blaffo Guetto prospect were headlined by a broad and high-grade
Read More
James Bay Minerals (ASX: JBY) (‘James Bay’) has entered a binding agreement that gives the Company the right to acquire up to 100% of the advanced Independence Gold Project, located in Nevada, United States of America. The Independence Project is presently owned by Independence Mining LLC, an incorporated joint venture between Battle Mountain Resources Pty
Read More
Diversified mining titan Rio Tinto (ASX: RIO) is set to purchase the “world-class” lithium chemical producer Arcadium Lithium in an effort to grow its position as a global leader in the production of energy transition commodities. Valued at US$6.7 billion, the all-cash deal represents a sturdy 90 per cent premium to Arcadium’s closing share price
Read More
Medical technology company Echo IQ (ASX:EIQ) has employed leading American healthcare executive, Dustin Haines, as new chief executive officer (CEO) to spearhead efforts to commercialise and scale its EchoSolv artificial intelligence powered platform in the lucrative US market. The innovative platform is designed to automatically identify patients at risk of structural heart disease with unparalleled
Read More
Regenerative medicine business Orthocell (ASX: OCC) has nailed down its first international regulatory approval for the group’s nerve repair product known as Remplir. The formal authorisation from the Health Sciences Authority in Singapore allows the company to begin sales in the nation and builds on its existing markets for the product in Australia and New
Read More